Results 271 to 280 of about 1,097,275 (327)

Role of Clinical Pharmacists in Antimicrobial Therapy for Patients with Septic Shock in the ICU. [PDF]

Med Sci Monit
Mai S, Wang Y, Zhu J, Yang B.
europepmc   +1 more source

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

Arthritis &Rheumatology, EarlyView.
Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...
Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro, Valentin Lacombe, Vincent Jachiet, Michael Zisapel, Iftach Sagy, Oshrat E. Tayer‐Shifman, David Ozeri, Shaye Kivity, Alessandro Tomelleri, Benjamin Terrier, Hagit Peleg, Thibault Comont, Karim Sacre, Pascal Woaye‐Hune, Laurent Arnaud, Estibaliz Lazaro, Vincent Grobost, Francois Lifermann, Maxime Samson, Samuel Ardois, Alice Garnier, Alexandre Maria, Alain Cantagrel, Aurore Meyer, Jean‐David Bouaziz, Mael Heiblig, Lorenzo Dagna, Elisa Diral, Olivier Kosmider, Ori Elkayam, Jérôme Hadjadj, Sophie Georgin‐Lavialle, Olivier Fain, Arsene Mekinian   +35 more
wiley   +1 more source

Do We Really Need a Perfect Vasoactive Agent for Low-middle Income Countries in Pediatric Septic Shock? [PDF]

Indian J Crit Care Med
Sharma PK.
europepmc   +1 more source

Identification of histone deacetylase inhibitor targeting type I interferon and B‐cell abnormalities in systemic lupus erythematosus

Arthritis &Rheumatology, Accepted Article.
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama, Hachiro Konaka, Yasuhiro Kato, Takayuki Shibahara, Chisato Nishizawa, Kohei Tsujimoto, JeongHoon Park, Eri Itotagawa, Tatsunori Jo, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Wataru Aoki, Ken J Ishii, Hyota Takamatsu, Atsushi Kumanogoh   +16 more
wiley   +1 more source

Early Vasopressin in Septic Shock-Promise, Paradox, and the Pursuit of Precision. [PDF]

Indian J Crit Care Med
Prakash J, Saran K, Choudhuri B.
europepmc   +1 more source

From Fluid Responsiveness to Prognosis: The Emerging Role of Point-of-Care Echocardiography in Sepsis. [PDF]

Diagnostics (Basel)
Piccioni A, Rozzi G, Spaziani G, Novelli M, Fuorlo M, Candelli M, Pignataro G, Santarelli L, Covino M, Gasbarrini A, Franceschi F.   +10 more
europepmc   +1 more source

TGFBI Inhibits the Pyroptosis of Macrophages to Ameliorate Septic Shock. [PDF]

J Cell Mol Med
Zou S, Li L, Lv B.
europepmc   +1 more source

Barriers to Cardiogenic Shock Recognition: A Qualitative Analysis. [PDF]

JACC Case Rep
Adie SK, Stein A, Pashun RA, Cantey EP, Konerman MC, Koelling TM, Steadman S, Ketcham SW.   +7 more
europepmc   +1 more source

Adjunctive terlipressin versus placebo in the treatment of refractory septic shock: a randomized, placebo-controlled trial. [PDF]

Crit Care
Tongyoo S, Chayakul C, Aritajati T, Tanyalakmara T.   +3 more
europepmc   +1 more source

Septic Shock and Multiorgan Failure Related to Liver Abscess Caused by Fish Bone Penetration of Duodenal Wall. [PDF]

Case Rep Gastrointest Med
Atiquzzaman M, Haque IU, Islam MM, Hamid T, Halim MR, Ahmed KN, Jesmin S, Hasan R, Al Masum QA, Sohan MA.   +9 more
europepmc   +1 more source